These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 11737585
1. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS. Kidney Int; 2001 Dec; 60(6):2109-17. PubMed ID: 11737585 [Abstract] [Full Text] [Related]
2. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Dusso AS, Pavlopoulos T, Naumovich L, Lu Y, Finch J, Brown AJ, Morrissey J, Slatopolsky E. Kidney Int; 2001 Mar; 59(3):855-65. PubMed ID: 11231340 [Abstract] [Full Text] [Related]
3. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Takahashi F, Finch JL, Denda M, Dusso AS, Brown AJ, Slatopolsky E. Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408 [Abstract] [Full Text] [Related]
4. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate. Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y. Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096 [Abstract] [Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
7. A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Cozzolino M, Lu Y, Sato T, Yang J, Suarez IG, Brancaccio D, Slatopolsky E, Dusso AS. Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1096-102. PubMed ID: 15998841 [Abstract] [Full Text] [Related]
8. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. Slatopolsky E, Cozzolino M, Lu Y, Finch J, Dusso A, Staniforth M, Wein Y, Webster J. Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289 [Abstract] [Full Text] [Related]
9. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Slatopolsky E, Finch J, Ritter C, Denda M, Morrissey J, Brown A, DeLuca H. Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144 [Abstract] [Full Text] [Related]
10. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ. J Clin Invest; 1996 Jun 01; 97(11):2534-40. PubMed ID: 8647946 [Abstract] [Full Text] [Related]
11. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats. Slatopolsky E, Finch J, Ritter C, Takahashi F. Am J Kidney Dis; 1998 Oct 01; 32(2 Suppl 2):S40-7. PubMed ID: 9808142 [Abstract] [Full Text] [Related]
12. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Slatopolsky E, Brown A, Dusso A. Am J Kidney Dis; 2001 Jan 01; 37(1 Suppl 2):S54-7. PubMed ID: 11158862 [Abstract] [Full Text] [Related]
13. Parathyroid growth and regression in experimental uremia. Taniguchi M, Tokumoto M, Matsuo D, Tsuruya K, Hirakata H, Iida M. Kidney Int; 2006 Feb 01; 69(3):464-70. PubMed ID: 16395258 [Abstract] [Full Text] [Related]
14. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells. Brown AJ, Ritter CS, Knutson JC, Strugnell SA. Nephrol Dial Transplant; 2006 Mar 01; 21(3):644-50. PubMed ID: 16221703 [Abstract] [Full Text] [Related]
15. Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats. Jara A, von Höveling A, Jara X, Burgos ME, Valdivieso A, Mezzano S, Felsenfeld AJ. Nephrol Dial Transplant; 2006 Apr 01; 21(4):917-23. PubMed ID: 16431896 [Abstract] [Full Text] [Related]
16. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. Naveh-Many T, Rahamimov R, Livni N, Silver J. J Clin Invest; 1995 Oct 01; 96(4):1786-93. PubMed ID: 7560070 [Abstract] [Full Text] [Related]
17. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E. Endocrinology; 1995 Apr 01; 136(4):1419-25. PubMed ID: 7895652 [Abstract] [Full Text] [Related]
18. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E. J Steroid Biochem Mol Biol; 2004 May 01; 89-90(1-5):507-11. PubMed ID: 15225829 [Abstract] [Full Text] [Related]
19. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats. Lewin E, Garfia B, Almaden Y, Rodriguez M, Olgaard K. Kidney Int; 2003 Jul 01; 64(1):63-70. PubMed ID: 12787396 [Abstract] [Full Text] [Related]
20. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD. Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley CM. Nephrol Dial Transplant; 2012 Jun 01; 27(6):2198-205. PubMed ID: 22036941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]